Glenmede Trust CO Na Alkermes Plc. Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Alkermes Plc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 514,948 shares of ALKS stock, worth $17.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

514,948

Previous 518,577 0.7%

Holding current value

$17.5 Million

Previous $14.5 Million 2.03%

% of portfolio

0.08%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$25.7 - $31.46 $93,265 - $114,168	-3,629 Reduced 0.7%	514,948 $14.8 Million
Q3 2024 Nov 13, 2024	SELL	$23.01 - $28.55 $127,406 - $158,081	-5,537 Reduced 1.06%	518,577 $14.5 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $120,297 - $141,184	5,183 Added 1.0%	524,114 $12.6 Million
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $966,741 - $1.19 Million	36,619 Added 7.59%	518,931 $14 Million
Q4 2023 Feb 13, 2024	SELL	$23.37 - $28.68 $223,627 - $274,438	-9,569 Reduced 1.95%	482,312 $13.4 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $20,132 - $23,689	-741 Reduced 0.15%	491,881 $13.8 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $27,518 - $32,654	971 Added 0.2%	492,622 $15.4 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $147,430 - $169,041	5,825 Added 1.2%	491,651 $13.9 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $1.31 Million - $1.57 Million	-59,914 Reduced 10.98%	485,826 $12.7 Million
Q3 2022 Nov 16, 2022	SELL	$22.0 - $31.87 $1.45 Million - $2.1 Million	-66,026 Reduced 10.79%	545,740 $12.2 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $1.77 Million - $2.05 Million	-67,140 Reduced 9.89%	611,766 $18.2 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $2.6 Million - $3.15 Million	112,655 Added 19.89%	678,906 $17.9 Million
Q4 2021 Feb 15, 2022	BUY	$21.47 - $32.08 $12.2 Million - $18.2 Million	566,251 New	566,251 $13.2 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $384 - $552	-25 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $6,282 - $9,161	-472 Reduced 94.97%	25 $0
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $546 - $679	-28 Reduced 5.33%	497 $9,000
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $2,982 - $3,831	105 Added 25.0%	525 $19,000
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $7,571 - $12,089	271 Added 181.88%	420 $12,000
Q2 2018 Aug 15, 2018	SELL	$40.56 - $51.36 $1.33 Million - $1.69 Million	-32,844 Reduced 99.55%	149 $6,000
Q4 2017 Feb 15, 2018	BUY	$47.69 - $55.39 $783,212 - $909,669	16,423 Added 99.11%	32,993 $1.81 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $814,581 - $902,236	16,570	16,570 $0

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.59B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Alkermes Plc. Transaction History